About Duchesnay USA

In 1970

Duchesnay started as a family-owned pharmaceutical company in Canada. In the late 1980s, a family member experienced a difficult pregnancy, but was unable to obtain treatment due to a lack of information regarding the safe use of medications in pregnancy.

In 1992

Duchesnay officially shifted its focus toward developing medications that are safe for use during pregnancy, thus becoming the first pharmaceutical company dedicated to safeguarding the health of pregnant women and their unborn babies.

In 2011

Duchesnay expanded to the United States and established Duchesnay USA to provide American women with access to a safe and effective treatment option for nausea and vomiting of pregnancy (NVP), commonly referred to as morning sickness, when conservative management fails.

Duchesnay today: A company dedicated to women’s health at every stage of life

Today, Duchesnay continues to evolve as a research-based pharmaceutical company whose primary goal is to improve women's health and quality of life during pregnancy and breastfeeding, while reducing the number of birth defects and minimizing the impact of maternal medical issues on newborns.

But Duchesnay’s commitment to women’s health does not stop at pregnancy and breastfeeding. Thus, Duchesnay is broadening its portfolio of products to offer therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives.

Our Values

In addition to ensuring our compliance with every law and regulation governing the pharmaceutical industry, Duchesnay abides by the highest internal standards of integrity, excellence and innovation.

These values are what have earned Duchesnay the respect, trust and support of stakeholders in the medical community worldwide.

Integrity

Every decision we make is guided by our unwavering commitment to honesty, openness and transparency in everything we do.

Excellence

Ensuring the quality, effectiveness and safety of every product we sell is our number one priority.

Innovation

Duchesnay is proud of the products we offer, but we never stop innovating. We continuously invest in research and development to create new and better treatment options to improve women’s health and quality of life at every stage.

picture our values

Social responsibility

Duchesnay and its employees are deeply committed to giving back to our community. That is why we are actively involved with charitable organizations such as the Autism Society of Greater Philadelphia.

The Autism Society of Greater Philadelphia's mission is to promote lifelong access and opportunities for persons within the autism spectrum and their families to be fully included, participating members of their communities through advocacy, public awareness, education and research related to autism.

Environmental responsibility

Duchesnay makes every effort to minimize its environmental footprint. We support various recycling programs and have implemented a variety of ecological initiatives, including opting for electronic rather than printed formats, prioritizing the use of eco-responsible materials and systems in our construction and renovation projects, and the installation of a geothermal heating and cooling system at our facilities.

Perinatal health initiatives supported by Duchesnay

Duchesnay supports a number of perinatal health initiatives involving university research and education for healthcare professionals in the field. To provide women and their families with clear and reliable information about how to help ensure a healthy pregnancy, we also support organizations and media aimed at non-professionals.

Compliance with all laws, regulations, company policies and other best practices applicable to the organization by all Duchesnay USA employees is critical to Duchesnay USA’s professional standards and corporate success. Duchesnay USA’s Compliance Program incorporates the fundamental elements addressed within the Office of the Inspector General’s (OIG) “Compliance Program Guidance for Pharmaceutical Manufacturers”.